BPC-157 in Connective-Tissue Models
The BPC-157 literature is concentrated in rodent connective-tissue work: tendon, ligament, and muscle. This piece walks through the specific injury models the research has actually used.
01 / BPC-157
Available as CELLA
| Sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
|---|---|
| Formula | C62H98N16O22 |
| Class | Synthetic pentadecapeptide |
BPC-157 is a 15-amino-acid synthetic peptide derived from a partial sequence of a protective protein isolated from human gastric juice. It is noted in the literature for stability against proteolytic breakdown, a property uncommon among short-chain peptides.
Research has examined BPC-157 in relation to fibroblast activity and growth-factor receptor expression in tendon-derived cell models. [Placeholder, replace with copy doc text.]
Studies have investigated BPC-157 in the context of angiogenic signalling and microvascular formation in preclinical models. [Placeholder, replace with copy doc text.]
The literature describes cytoprotective effects observed across a range of tissue types in laboratory and animal research. [Placeholder, replace with copy doc text.]
Library
The BPC-157 literature is concentrated in rodent connective-tissue work: tendon, ligament, and muscle. This piece walks through the specific injury models the research has actually used.
BPC-157 is the product of a research programme run since the 1990s by Sikiric and colleagues at the University of Zagreb. The published record spans gastrointestinal, tendon, ligament, muscle, and central nervous system models, almost entirely in rats.
For research purposes only. Not for human or veterinary consumption. Not for use in diagnostic, therapeutic, or clinical procedures.